Related references
Note: Only part of the references are listed.Efficacy of lianhuaqingwen granules in the management of chronic rhinosinusitis without nasal polyps
Lin Lin et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2020)
Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease
Shuang Ji et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases
Zhan Zhang et al.
VIROLOGICA SINICA (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment
Zhenwei Wang et al.
BIOSCIENCE TRENDS (2020)
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
Li Runfeng et al.
PHARMACOLOGICAL RESEARCH (2020)
Shufeng Jiedu Capsule protect against acute lung injury by suppressing the MAPK/NF-κB pathway
Zhengang Tao et al.
BIOSCIENCE TRENDS (2014)
Effects of huoxiangzhengqi liquid on enteric mucosal immune responses in mice with Bacillus dysenteriae and Salmonella typhimurium induced diarrhea
Yin-Hui He et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Share Paper
